Chison Medical Technologies Co., Ltd. (SHA:688358)
28.23
-0.12 (-0.42%)
Sep 4, 2026, 3:00 PM CST
SHA:688358 Revenue
Chison Medical Technologies had revenue of 114.17M CNY in the quarter ending June 30, 2026, with 5.28% growth. This brings the company's revenue in the last twelve months to 441.10M, down -3.54% year-over-year. In the year 2025, Chison Medical Technologies had annual revenue of 435.81M, down -7.02%.
Revenue (ttm)
441.10M
Revenue Growth
-3.54%
P/S Ratio
7.18
Revenue / Employee
944.55K
Employees
467
Market Cap
3.17B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 435.81M | -32.89M | -7.02% |
| Dec 31, 2024 | 468.70M | -15.14M | -3.13% |
| Dec 31, 2023 | 483.84M | 103.00M | 27.04% |
| Dec 31, 2022 | 380.84M | -16.97M | -4.27% |
| Dec 31, 2021 | 397.81M | 64.72M | 19.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.69B |
| Ningbo David Medical Device | 584.68M |
| Medprin Regenerative Medical Technologies | 400.85M |
| Tellgen | 392.11M |
| Nanjing Medlander Medical Technology | 383.30M |
| Shanghai General Healthy Information and Technology | 371.61M |
| CareRay Digital Medical Technology | 319.79M |
| Beijing Leadman Biochemistry | 317.79M |